Generic name (INN) · Small Molecule
betovumeline
betovumeline is a generic name (inn) for ML-007C-MA, developed by MapLight Therapeutics, Inc..
- Status
- Phase 2 for Schizophrenia
- Mechanism
- M1 Agonist
- Developer
- MapLight Therapeutics, Inc.
Programs
- ML-007C-MA for SchizophreniaPhase 2Active
- ML-007C-MA for Alzheimer's disease psychosisPhase 2Recruiting
Also known as
- ML-007C-MA
- 286930-03-8
- ML-007C/PAC
- ML-007/PAC
- ML-007C
- ML-007
- 1314018-44-4
- MPL-0527
- fesoterodine
- fesoterodine fumarate